Wird geladen...
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin
Osteosarcoma (OS) is the most common malignant bone tumor and a leading cause of cancer‐related deaths in children and adolescents. Current standard treatments for OS are a combination of preoperative chemotherapy, surgical resection, and adjuvant chemotherapy. Cisplatin is used as the standard chem...
Gespeichert in:
| Veröffentlicht in: | Pharmacol Res Perspect |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387887/ https://ncbi.nlm.nih.gov/pubmed/32725721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.632 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|